"In patients with COVID-19, we continue to see a relentless, self-amplifying cycle of inflammation and clotting in the body," one researcher said. 

Anticoagulation therapies are an important part of treating COVID-19 patients—but there appears to be no benefit to taking a more aggressive approach.

Experiencing a stroke while your body is already battling COVID-19 can be especially dangerous, this new study suggests. 

World Stroke Day is on the horizon, and the American Stroke Association is highlighting the potential power of prevention. 

Long-term anticoagulation can be recommended for AFib patients 90 years old and older, according to new research. 

The researchers emphasized the value of green leafy vegetables, yellow vegetables, whole grains, coffee, tea and wine.

The newly approved solution was designed for the treatment of patients with PAD in the superficial femoral artery and proximal popliteal artery.

The journal is expected to begin publishing by early 2021.

The approval comes after Medtronic reported the successful results of a clinical study focused on 200 patients.

The meta-analysis, published in the American Journal of Cardiology, explored data from six different randomized trials.